Takeda Makes Senior AppointmentsBy
Takeda Pharmaceutical Company Limited (Takeda) reports that Christophe Weber's official start date as Takeda's chief operating officer (COO) is April 1, 2014. Mr. Weber is expected to become president and representative director, in addition to COO upon approval at Takeda’s Ordinary General Meeting of Shareholders and the Board of Directors Meeting in late June 2014. At that time, the current president and CEO, Mr. Yasuchika Hasegawa, will assume the role of chairman and CEO.
Upon becoming COO, Mr. Weber will be responsible for all operational activities and report to Mr. Hasegawa. As chairman and CEO, Mr. Hasegawa will continue to take responsibility for the mid-to-long-term corporate strategy as well as important global management policies.
Upon appointment as COO, Mr. Weber will reside in Japan, conducting his duties from Tokyo.